Manufacturing roundup: Aspen teams up with the Serum Institute; Porton secures several strategic partnerships

While South African-based manufacturer Aspen looks at a possible change in direction for producing Covid-19 vaccines for the African continent, the company has secured a new contract with a major vaccine player.

The Serum Institute of India and Aspen have entered into a 10-year agreement, in which Aspen will manufacture and distribute four of its vaccines for the African market, with some of those vaccines being available for The Serum Institute to also distribute on the continent.

The deal will see Aspen produce its pneumococcal vaccine, rotavirus vaccine, polyvalent meningococcal vaccine and hexavalent vaccines, as The Serum Institute lends its expertise.

On top of this work with The Serum Institute, Aspen also announced that it expects to receive grant funding from the Bill & Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations (CEPI) to support vaccine manufacturing abilities in Africa.

“The agreement concluded with the Serum Institute,…
Click here to view original post